Tami Mark

RTI uses cookies to offer you the best experience online. By clicking “accept” on this website, you opt in and you agree to the use of cookies. If you would like to know more about how RTI uses cookies and how to manage them please view our Privacy Policy here. You can “opt out” or change your mind by visiting: http://optout.aboutads.info/. Click “accept” to agree.

Search Results

Filter by Type

Filter by Year

Filter by Focus Area

Filter by Solution

Filter by Center

Search Results

Trump is coming for Obamacare again

Association of formulary prior authorization policies with buprenorphine-naloxone prescriptions and hospital and emergency department use among Medicare beneficiaries

Evaluation of a tablet PC technology to screen and educate oncology patients

National Estimates of Behavioral Health Conditions and Their Treatment Among Adults Newly Insured Under the ACA

How patient centered are addiction treatment intake processes?

Growth in Spending on and Use of Services for Mental and Substance Use Disorders After the Great Recession Among Individuals With Private Insurance

Pneumococcal pneumonia and influenza vaccination: Access to and use by US Hispanic Medicare beneficiaries

Webinar: How to Improve Addiction Treatment by Systematically Tracking Patient Outcomes

Productivity Losses Among Treated Depressed Patients Relative to Healthy Controls

Retrospective observational study of patients with chemotherapy-related anemia receiving erythropoietic agents

Spending on mental and substance use disorders projected to grow more slowly than all health spending through 2020

She paid nothing for opioid painkillers. Her addiction treatment costs more than $200 a month.

Expert available to comment on DOJ guidance on ADA protections for people with opioid use disorders

Association of Arizona's implementation of a behavioral health crisis response system with suicide hospitalizations

Pandemic stress and loneliness are making addiction more common: When to get help

Are medications for alcoholism underutilized? An analysis of private sector and medical claims

New study aims to improve patient retention rates and outcomes in substance abuse treatment

The Effects of Antidepressant Step-Therapy Protocols on Pharmaceutical and Medical Utilization and Expenditures

Impact of the coronavirus pandemic on substance use disorder treatment: Findings from a survey of specialty providers in California

Adherence to buprenorphine treatment guidelines among individuals with an opioid use disorder who have private insurance